Published in Hospital Business Week, July 22nd, 2007
Study 1: A report, "Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer," is newly published data in Carcinogenesis. According to recent research from the United States, "Xeroderma pigmentosum complementation group C (XPC) is responsible for DNA damage recognition in the initial steps of the nucleotide excision repair pathway. Genetic variations in the XPC gene may be associated with impaired protein function and increased risk for bladder cancer."
"To elucidate the roles of common polymorphisms of XPC in the etiology of bladder cancer, we...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week